Abstract
Lipoproteins are complexes composed of apolipoproteins and noncovalently bound lipids which are found in human plasma. They can be isolated from plasma by sequential ultracentrifugation and they are named according to their floating densities: very-low-density lipoproteins (VLDL), low-density lipoproteins (LDL) and high-density lipoproteins (HDL). They differ in lipid to protein ratios and in their apolipoprotein composition. In epidemiological studies it was shown that high concentrations of LDL in plasma are associated with a high risk for coronary heart disease, whereas a high concentration of HDL seems to be a protection factor for a myocardial infarction. Apolipoproteins are separated from lipoproteins by the extraction of lipids with ethanol and ether. Apolipoproteins bind lipids, serve as cofactors of lipolytic enzymes and represent ligands for the cellular recognition of lipoproteins on plasma membrane-bound receptors[1,2]. Major structural components of VLDL are apolipoproteins B,E,C-II and C-III, whereas the major apolipoprotein of LDL is apo B, while HDL is primarily composed of apolipoproteins A-I and A-II. The amino acid sequence of all apolipoproteins is known [3]. Apo A-I is a cofactor in the activation of the cholesterol esterifying enzyme lecithin-cholesterol acyltransferase (LCAT) and seems to be the specific ligand in the cellular uptake of HDL [4].
Keywords
- Tryptic Peptide
- HPLC Chromatogram
- Lipolytic Enzyme
- Cholesterol Acyl Transferase
- Major Structural Component
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
P.N. Herbert, G. Assmann, A.M. Gotto,Jr, and D.S. Fredrickson: in The Metabolic Basis of Inherited Disease. 1982. Editors: J.B. Stanbury, J.B. Wyngaarden, D.S. Fredrickson, J.L. Goldstein and M.S. Brown, McGraw-Hill, New York, pp 589–621.
G. Assmann: Lipid Metabolism and Atherosclerosis (Schattauer-Verlag, Stuttgart, New York, 1983 )
H.B. Brewer,Jr, T. Fairwell, A. Larne, R.Ronan, A.Houser and T. J. Bronzert: Biophys.Res.Commun. 80, 623 (1978)
G. Schmitz, H. Robenek, U. Lohmann —Ind G. Assmann: EMBO 4, 613 (1985)
H.J. Menzel, R.G. Kladetzky and G. Assmann: J.Lipid Res. 23, 915 (1982)
H.J. Menzel, G. Assmann, S.C. Rall et al.:J. Biol. Chem. 29 3070, (1984)
G. Assmann, H.J. Menzel, R.G. Kladetzky and G. Büttner: J. Clin. Chem. Clin. Biochem. 22, 585, (1984)
J.Y. Chang, D. Brauer, B. Wittmann-Liebold: FEBS Lett. 93, 205 (1978)
P. Steffens, E. Niehuis, T. Friese and A. Benninghoven: —in Springer series: Chemical Physics, Vol 25, 1983, pp 111–117
A. Benninghoven and V. Anders: Org. Mass Spectrom. 19, 345, (1984)
A. Benninghoven and W. Sichtermann: Anal. Chem. 50, 1180, (1978)
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1986 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Jabs, HU., Walter, M., Assmann, G., Benninghoven, A. (1986). The Application of Time-of-Flight Secondary Ion Mass Spectrometry in the Characterization of Apolipoprotein Mutants. In: Benninghoven, A. (eds) Ion Formation from Organic Solids (IFOS III). Springer Proceedings in Physics, vol 9. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-82718-1_16
Download citation
DOI: https://doi.org/10.1007/978-3-642-82718-1_16
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-82720-4
Online ISBN: 978-3-642-82718-1
eBook Packages: Springer Book Archive